SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-164587
Filing Date
2024-06-20
Accepted
2024-06-20 17:23:34
Documents
14
Period of Report
2024-06-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d660943d8k.htm   iXBRL 8-K 39658
2 EX-3.1 d660943dex31.htm EX-3.1 7442
  Complete submission text file 0001193125-24-164587.txt   181091

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pepg-20240620.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pepg-20240620_lab.xml EX-101.LAB 19482
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pepg-20240620_pre.xml EX-101.PRE 12143
17 EXTRACTED XBRL INSTANCE DOCUMENT d660943d8k_htm.xml XML 3962
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 241057523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)